Nutex Health Inc. (NUTX)
- Previous Close
0.6551 - Open
0.6492 - Bid --
- Ask --
- Day's Range
0.6399 - 0.7290 - 52 Week Range
0.5000 - 10.7550 - Volume
866,852 - Avg. Volume
261,310 - Market Cap (intraday)
34.667M - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
-- - EPS (TTM)
-1.0500 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.00
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
www.nutexhealth.com800
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NUTX
Performance Overview: NUTX
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUTX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUTX
Valuation Measures
Market Cap
32.56M
Enterprise Value
286.31M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.12
Price/Book (mrq)
0.53
Enterprise Value/Revenue
1.16
Enterprise Value/EBITDA
-19.64
Financial Highlights
Profitability and Income Statement
Profit Margin
-18.49%
Return on Assets (ttm)
-0.19%
Return on Equity (ttm)
-43.55%
Revenue (ttm)
247.65M
Net Income Avi to Common (ttm)
-45.79M
Diluted EPS (ttm)
-1.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
22M
Total Debt/Equity (mrq)
348.59%
Levered Free Cash Flow (ttm)
472.97k
Research Analysis: NUTX
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell